The Centers for Medicare & Medicaid Services yesterday updated its guidance related to the 20% inpatient prospective payment system diagnosis-related group rate add-on for patients diagnosed with COVID-19.

For inpatient admissions occurring on or after Sept. 1, 2020, claims eligible for the 20% add-on will be required to have a positive COVID-19 laboratory test documented in patients’ medical records.

Read the AHA Special Bulletin for additional information on this policy’s importance to hospitals and health systems.

Related News Articles

Headline
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…
Headline
The Centers for Medicare & Medicaid Services April 11 issued a proposed rule for the skilled nursing facility prospective payment system for fiscal year…
Headline
The Centers for Medicare & Medicaid Services April 11 issued a proposed rule for the inpatient psychiatric facility prospective payment system for fiscal…
Headline
The Centers for Medicare & Medicaid Services April 11 released the fiscal year 2026 proposed rule for inpatient rehabilitation facilities. The rule would…
Headline
The Centers for Medicare & Medicaid Services April 11 proposed increasing the long-term care hospital standard rate payments by 2.2% in fiscal year 2026…
Headline
The Centers for Medicare & Medicaid Services April 11 issued a proposed rule that would increase Medicare inpatient prospective payment system rates by a…